Data as of Q4 2025 (Dec 31, 2025)

Crestline Management, LP

โ€ขCIK: 1536054โ€ขFiling: Q4 2025

**Crestline Management, LP** A focused, concentrated portfolio managing $53M across three core positions. The strategy is heavily weighted toward **DNLI**, representing $46.4M of the total assets. Secondary allocations include **SANA** at $5.0M and **EGHT** at $2.0M. This structure indicates a high-conviction, deep-value approach within its limited investment universe.

Total AUM
$53.3M
QoQ Performance
-8.2%
Positions
3
Top 10 Concentration
100.0%
Latest Filing
Q4 2025

Top Holdings Allocation

DNLI
SANA
DNLI87.0%
SANA9.3%
EGHT3.7%

๐Ÿ“ˆ Biggest Buys

No new positions or increases this quarter

๐Ÿ“‰ Biggest Sells

DNLI
DENALI THERAPEUTICS INC
-17.6%
87.0% of portfolio
SANA
SANA BIOTECHNOLOGY INC
-33.0%
9.3% of portfolio

Sector Breakdown

Other100.0%

Changes from Q3 2025

โ†“2 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023